December 5, 2016 Columns by admin MS Patientās Pick of the Weekās News: UV light, Parasite Protein, Copper, Stem Cells, Palliative Here is my Pick of the Weekās news, as published in Multiple Sclerosis News Today. UV Light May Lead Way to New Treatment for MS and Inflammation Now this might be exciting, if turns out that ultraviolet light can truly be the basis of new treatments that…
November 28, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Stem Cells, Sun Scares, T-Cells, and More This is my Pick of the Weekās News, as published by Multiple Sclerosis News Today. New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M A news story about a new company raising nearly $50 million to further develop stem cell transplants that…
November 21, 2016 Columns by admin MS Patientās Pick of the Weekās News: DMTs, Availability, Cannabis, Imaging, Sexual Dysfunction Here is my Pick of the Weekās News as published by Multiple Sclerosis News Today. Effectiveness and Safety of DMDs Top Patient Concerns with These Therapies, Survey Says Having progressive multiple sclerosis, the issue of drugs that are disease modifying therapies (DMTs) has never arisen in my…
November 14, 2016 Columns by admin MS Patientās Pick of the Weekās News: Immunity, Marijuana, Late-onset, Genetics and Reimbursements Hereās my Pick of the Weekās News, as published by Multiple Sclerosis News Today. Immune System May Harbor Natural Way of Fighting MS, Other Autoimmune Diseases A genetic key to a possible natural way of battling MS could be worth further work. A variant in theĀ TYK2Ā gene, which encodes…
November 10, 2016 Columns by admin Research About Why Interferon Can Fail is Welcome I have made no secret of my distrust of the side effects from many of the disease-modifying therapies (DMTs) that are used mainly in the fight against relapsing multiple sclerosis (MS).Ā The fact that the most serious, albeit rare, side effects listed by the manufacturers of some drugs, include “death”…
November 7, 2016 Columns by admin MS Patientās Pick of the Weekās News: Ampyra, Breast Cancer, Bourbon, Myelin, Lemtrada Hereās my Pick of the Weekās News published last weekĀ in Multiple Sclerosis News Today. Ampyra Helps MS Patients Not Only Walk Better, But Feel Better Too, Study Reports This is news of encouraging research. Results from a Phase 2 clinical trial showed that treatment withĀ AmpyraĀ (prolonged-release fampridine)…
November 3, 2016 Columns by admin HSCT in Moscow, Day by Day Doesnāt time fly? It seems only yesterday that I was preparing to goĀ to Moscow, yet tomorrow will be three weeks since my return. I have written enough about my experiences at the A.A. Maximov center so, today, weāll take a look at how HSCT progresses, step by step. The…
October 24, 2016 Columns by admin MS Patient’s Pick of the Weekās News: Lemtrada, Umbilical Stem Cells, Wheat Proteins and Research Here is my pick of the weekās news items, as published in Multiple Sclerosis News Today. Lemtrada Seen to Help Reverse MS Disability in People in Earlier Stages of Disease A medication that might not just stop but reverse disability of people with relapsing MS? Now, this is…
October 20, 2016 Columns by admin Hormones and Diet Help Relieve Woman’s MS-Related Fatigue A woman who says her life was made miserable by fatigue caused by multiple sclerosis (MS), claims she is on the road to recovery because she has taken control of her body and is using a combination of hormones and diet. Instead of relying on conventional treatment, she is…
October 17, 2016 Columns by admin MS Patientās Pick of the Weekās News: Remyelination, Ocrevus, Mushrooms, Heparin, Exercise Here, I comment on my Pick of the Weekās News, as published in Multiple Sclerosis News Today. Myelin Regeneration Achieved in Mouse Model of MS Remyelination is one of the most exciting developments in the treatment of MS. Therapies aimed at regenerating the myelin sheath can work to…
October 3, 2016 Columns by admin MS Patientās Pick of the Weekās News: Tecfidera, T-cells, Test Dosing and More Hereās my pick of this weekās news, as published in Multiple Sclerosis News Today. How Tecfidera Works to Reduce MS Relapses Finally Discovered, May Lead to Better Treatments The possibility that this discovery may lead to the development of new drugs with fewer side effects is good news.
September 26, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Most Effective, Brain MRIs, Vit D3, Lipoic Acid, Modeling Hereās my Pick of this Weekās News, as published by Multiple Sclerosis News Today. This week is a rather special one because itĀ spotlights the work done by our news team in following and reporting the major events at ECTRIMS 2016. Here, I set out my choice of what I…
September 23, 2016 Columns by admin Familial Connections Cannot Be Coincidences, Can They? Life can be really strange and not always fathomable to someone like me who is not blessed with neither medical nor scientific qualifications. On a purely technical basis, I am just an ordinary guy. What I do know about diseases, illnesses and conditions ā call them what you will ā…
September 21, 2016 Columns by admin MS Brothers Able to Remain at Home Thanks to Caregiving Support Continuing to live in your own home when you can no longer look after yourself is an ideal many people seek to aspire to ā but itās not easy. Outside help is often needed. Alex Camarillo is one perfect example of this. He is 35 years old, has severe…
September 19, 2016 Columns by admin MS Columnist’s Picks of the Week: ECTRIMS, Biomarkers, Cannabis, Migraine, Research Award Hereās my Pick of the Weekās News as published by Multiple Sclerosis News Today. #ECTRIMS2016 was undoubtedly the star of the week ECTRIMS, the European Committee for Treatment and Research in Multiple Sclerosis, dominated the news stories of the week when it held its 32nd congress in London. There…
September 18, 2016 Columns by admin #MSLIFE2016 – Sunday Brings Presentations, Activities Galore A veryĀ full day of activities is planned for today at MS Life, inside London’s ExCel exhibition and convention center. Altogether, there are 15 presentations on the agenda. Three are in the MS Life theatre, and three more are in each of the following four zones: Managing my MS Symptoms;…
September 17, 2016 Columns by admin #ECTRIMS2016 #MSLIFE2016 – Saturday: Congress Closes, MS Life Opens Londonās ExCel exhibition and convention center is set for a busy Saturday as ECTRIMS winds down today and MS Life opens just down the hall. Organized by the MS Society, MS Life is billed as the biggest MS family event in Europe. With ECTRIMS drawing to a close, many…
September 16, 2016 Columns by admin #ECTRIMS2016 ā Hereās my Pick of Friday’s Best at the Congress Friday carries on the ECTRIMS congressās style of so much going on that it must be difficult for delegates to decide which sessions to attend and which ones they can afford to miss.Ā Of course, not everyone can make the same choice but, having delved into the agenda, here…
September 15, 2016 Columns by admin #ECTRIMS2016 ā My Pick of Thursdayās Congress Highlights Another full day, today,Ā at Londonās ExCel center andĀ numerous sessions, presentations, and debates to attract the attention of delegates attending ECTRIMS. After sifting through the agenda, here are my picks of Thursday’s highlights: This morning sees the beginning of the congressās plenary sessions, featuring a lecture about āMS diagnosis and…
September 14, 2016 Columns by admin #ECTRIMS2016 – Patient Empowerment Is One of My Highlights for Day 1 Europeās annual congress discussing treatment, including Patient Empowerment, and research in multiple sclerosis is now underway in London.Ā The 32ndĀ congress is being held from today until Saturday, when it draws to a close at lunchtime. The agenda is absolutely jammed full of topics being covered in a multitude of sessions…
September 12, 2016 Columns by admin MS Patientās Pick of the Weekās News: Myelin Repair, Shape Changers, Misdiagnoses, and Virtual Reality Here is my Pick of the Weekās News, as published in Multiple Sclerosis News Today. Breast Cancer Therapy, Tamoxifen, May Promote Myelin Repair in MS Remyelination could beĀ a new role in MS therapy for a drug that has been used to treat breast cancer for some…
September 8, 2016 Columns by admin #ECTRIMS2016 – Stay Up to Date with My Pick of Congress Highlights The show comes to town in the next week with ECTRIMS hosting what it describes as āthe worldās largest annual international conferenceā devoted to basic treatment and clinical research in multiple sclerosis. It is being held in Londonās ExCel center from Wednesday to Saturday morning, and will be followed…
September 7, 2016 Columns by admin James Received HSCT for Free, as He Lives in the UK Virtually all the talk about availability of HSCT1 as an MS treatment includes the need to travel long distances to other countries, but U.K. residents can receive the treatment in London, avoiding the journey overseas.Ā Whatās more, it is provided through the countryās social National Health Service (NHS) so, like…
September 5, 2016 Columns by admin MS Patientās Pick of the Weekās News: Siponimod, Thymosin Patent, Orphan Drug, Lifestyle, and Lymphopenia Risk Hereās my Pick of the Weekās News, as published in Multiple Sclerosis News Today. Gilenya-like Therapy Shows Benefit in Secondary Progressive MS Patients in Phase 3 Trial Hereās a potentially encouraging development for anyone with SPMS. Patients withĀ secondary progressive multiple sclerosisĀ (SPMS) who were treated withĀ BAF312 (siponimod),…
September 2, 2016 Columns by admin Taming Heat Sensitivity at 100 Degrees Many people voiced their concerns to me about anyone with MS moving to live in aĀ sunny climate. That worry is understandable. With a disease that includes heat sensitivity, where even a hot shower can make you worse, how can any MS patient move to live in an area where…
August 31, 2016 Columns by admin Welcome or Not, FDA Focuses on Stem Cell Treatments News that the U.S. Food and Drug Administration (FDA) is to hold a public hearing next month to consider greater oversight of stem cell clinics operating in the country is as welcome as it is late. I say “late” because, while the regulators have been twiddling their fingers,…
August 29, 2016 Columns by admin MS Patientās Pick of the Weekās News: Umbilical Cells, Early Drugs, REAL Research, Hemoglobin, and Fatigue Hereās my Pick of the Weekās News, as published by Multiple Sclerosis News Today. Umbilical Cord Blood-derived Cell Therapy Promotes Remyelination in Mice Now this is different, using umbilical cord stem cells. A cell therapy product derived from human umbilical cord blood cells may be…
August 26, 2016 Columns by admin Help for Anyone Newly Diagnosed with MS Being diagnosed with MS can be more than a bit of a shock at first. Yes, you finally know what youāve got, what all those symptoms you’ve having mean, and you have heard what your neurologist told you. Well, you may have heard, but you didnāt take it in…
August 24, 2016 Columns by admin My Life is My Own, MS Cannot Have It It is often said that real life mimics television, and one hitĀ TV series certainly reflects the theme: āmy life is my own, MS cannot have it.ā During the 1960s, 1967ā68 to be exact, an iconic television show ran on Sunday nights called “The Prisoner.” It starred Patrick McGoohan as…
August 22, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Blood Tests, Marijuana, Cameras, and More Hereās my Pick of the Weekās News, as published in Multiple SclerosisĀ News Today. Blood Test Seen to Distinguish MS from Other Neurological Conditions A faster way to tell the difference between neurological diseases could mean earlier access to treatment for MS patients. Researchers atĀ Michigan State…